Susan G. Kreissman
Elite in Embryonal Tumor with Multilayered Rosettes
Elite in Embryonal Tumor with Multilayered Rosettes

Overview

Susan Kreissman is a Pediatrics provider in Durham, North Carolina. Dr. Kreissman has been practicing medicine for over 40 years and is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hepatoblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 30 peer reviewed articles and participating in 48 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 22 articles and participated in 15 clinical trials in the study of Embryonal Tumor with Multilayered Rosettes.

Graduate Institution
New York University Mount Sinai School Of Medicine, 1985
Specialties
Pediatrics
Licenses
Pediatric Hematology-Oncology in NC
Board Certifications
American Board Of Pediatrics, Pediatric Hematology-Oncology
Fellowships
Pediatric Hematology-Oncology, Children's Hospital, Dana Farber Cancer Center (Massachusetts)
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Duke Children's Health Center Hematology/Oncology Clinic
2301 Erwin Rd, Durham, NC 27710
Other Locations
Duke Children's Hematology/Oncology Creekstone
4709 Creekstone Dr, Durham, NC 27703
Duke Children's Hospital & Health Center
2301 Erwin Rd, Durham, NC 27710

Additional Areas of Focus

Dr. Kreissman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


48 Clinical Trials

Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
View 46 Less Clinical Trials
Similar Doctors
Henry S. Friedman
Distinguished in Embryonal Tumor with Multilayered Rosettes
Neurosurgery | Hematology | Oncology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Neurosurgery | Hematology | Oncology

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
 (9.9 miles away)
Experience:
48+ years
Languages Spoken:
English
Offers Telehealth

I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.

Daniel Landi
Distinguished in Embryonal Tumor with Multilayered Rosettes
Pediatrics
Distinguished in Embryonal Tumor with Multilayered Rosettes
Pediatrics

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
 (9.9 miles away)
Experience:
16+ years
Languages Spoken:
English
Offers Telehealth

I am a pediatric neuro-oncologist at Duke and member of the Pediatric Brain Tumor Program. Our multidisciplinary team is committed to providing cutting-edge, compassionate care to children and young adults with brain and spinal cord tumors. As part of the Preston Robert Tisch Brain Tumor Center, we are developing powerful, exciting immune-based therapies for our patients. I am very proud to be a part of the team at Duke and am constantly inspired and motivated by my patients and families. Dr. Landi is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Pediatric Low-Grade Glioma (pLGG), Gliomatosis Cerebri, and Anemia.

Gerald A. Grant
Distinguished in Embryonal Tumor with Multilayered Rosettes
Neurosurgery | Pediatrics
Distinguished in Embryonal Tumor with Multilayered Rosettes
Neurosurgery | Pediatrics

Duke Cancer Center Brain Tumor Clinic

20 Duke Medicine Cir, 
Durham, NC 
 (9.9 miles away)
Experience:
31+ years
Languages Spoken:
English
Offers Telehealth

I am a neurosurgeon and care for children and young adults. I focus on minimally invasive approaches to improve the quality of life of my patients. Your patient experience is very important to me, and I will strive to provide the best possible care for you and your family. I will always go the extra mile to try to improve your care. I care for conditions that affect the brain and spine, including tumors, epilepsy, Chiari malformations, hydrocephalus, craniosynostosis, vascular conditions such as AVMs and Moya Moya disease, and complex tethered cords. I learn so much from my patients and really look forward to getting to know all of them. I strive to bring the best collaborative team to the table to achieve the best possible outcome. I am delighted to provide the most innovative, holistic, and compassionate neurosurgical care at Duke Health. I am also a professor and Chair of the Department of Neurosurgery. Dr. Grant is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Chiari Malformation Type 2, Medulloblastoma, Syringomyelia, Posterior Fossa Decompression, and Osteotomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kreissman's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile